MedPath

Comparison of Remifentanil With Dexmedetomidine or Midazolam in Regards of Sedation Effectivity and Postoperative Cognitive Functions in Cystoscopies

Not Applicable
Completed
Conditions
Postoperative Cognitive Functions
Registration Number
NCT01491009
Lead Sponsor
Gazi University
Brief Summary

The aim of the study was to compare the effects of remifentanil-dexmedetomidine and remifentanil-midazolam with mini-mental state examination (MMSE) in monitored anesthesia care (MAC) patients undergoing cystoscopy.

Detailed Description

Forty patients undergoing cystoscopy receiving remifentanil infusion of 0.05 microgram per kg-1 min-1 were randomized into two groups: Either dexmedetomidine 1 microgram per kg -1 (GroupD) or midazolam 0.2 mg kg-1h-1 (GroupM) were administered intravenously for the first 10 minutes. Subsequently anesthesia was maintained by using the bispectral index(BIS) as a continuous infusion of dexmedetomidine 0.2-0.7 microgram per kg-1h-1 or midazolam 0.05-0.15 mgkg-1h-1. Heart rate, mean arterial pressure, MMSE, sedation and the patient's and surgeon's satisfaction were determined.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • patients with indication of cystoscopy must be able to have sedation
Exclusion Criteria
  • hypersensitivity to drugs used
  • morbid obesity
  • coronary disease
  • diabetes mellitus and other endocrinologic diseases
  • pregnancy
  • psychomotor diseases

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Degree of sedative efficiencyDuring cystoscopy procedure

Bispectral Index (BIS) was used.

Degree of cognitive functionsPostoperative 60 minutes

mini-mental state examination(MMSE) test was used.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Gazi University Faculty of Medicine Hospital

🇹🇷

Ankara, Turkey

© Copyright 2025. All Rights Reserved by MedPath